Clinical Trial Update: Safety and Efficacy of the Therapeutic Vaccine GI-5005 Versus Placebo for the Treatment of Chronic Hepatitis C Infection [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update reports safety and preliminary efficacy results of GI-5005 versus placebo for chronic hepatitis C infection. The study assesses to…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• GI-5005

Snippet

Sponsor: GlobeImmune | Conditions: Hepatitis C | Phase 1 | Status: COMPLETED